Shilpa Medicare skyrockets by 10.47 per cent on a weak market day!
The board of the company also has recommended a dividend of Rs 1.10 per equity share for the financial year ended March 31, 2022.Ā Ā
The shares of Shilpa Medicare soared 10.47 per cent to Rs 453.25 on BSE after the company announced promising results for the quarter that ended on March 31, 2022.
The company's quarterly consolidated financials reveal that the operating profit for Q4FY2022 stood at Rs 79.22 crore compared to Rs 33.12 crore for Q4FY2021, an incredible increase of 139.23 per cent. Net sales for Q4FY2022 stood at Rs 340.60 crore, recording an increase of 63.73 per cent as compared to the net sales of Rs 208.03 crore in the same quarter last year. The net profit has also been on the upper side and stands at Rs 30.55 crore during the same period, which was at Rs 7.96 crore, higher by 283.65 per cent from Q4FY22.
Shilpa Medicare Ltd, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces & exports consistently high-quality active pharmaceutical ingredients, fine chemicals, intermediates, herbal products, and speciality chemical products using sophisticated technology, meticulously following international specifications.
The company has earned its spurs as a successful and reliable partner within the pharmaceutical industry. Buyers within the country and from across the borders count on its fast track integrated process development and finely-honed expertise of its skilled and experienced personnel. The company is already exporting to the USA, Canada, Australia, Japan, and European countries viz., Germany, Switzerland, Netherlands, Belgium, Spain, Greece, Cyprus, Italy, United Kingdom, etc., South American countries including Mexico, Brazil, Columbia, etc along with African countries like Kenya, Nigeria and West Indies, etc. It also includes Asian countries like Singapore, Taiwan, China, Malaysia, Thailand, and closer to home to Iran, Egypt, Pakistan & Bangladesh.
The board of the company also has recommended a dividend of Rs 1.10 per equity share for the financial year ended March 31, 2022.
Related articles
-
Keep an eye on this stock, which was locked in the upper circuit on November 30
-
Keep an eye on this stock, which was locked in the upper circuit on November 21
-
This company is considering a buyback proposal on November 25. Do you own it?
-
From Rs 160 to Rs 827: This multi-bagger stock has gained over 392 per cent year to date; to pay 6:1 bonus share soon
-
Keep an eye on this stock, which was locked in the upper circuit on November 15
-
Shares of this chemical company have gained more than 200 per cent! Do you own this stock?
-
2,000 per cent return multibagger stock, company acquires 80 per cent stake in Switzerland based firm Von Roll Holding AG
-
1,125 per cent Return multibagger stock: Announced Stock Split in 1:2, Net Profit zooms by 168 per cent in June quarter
-
An investment of Rs 1 lakh has grown to Rs 28 lakhs, Stock trading in blue sky zone
-
350 Percent return multibagger stock: Board announced 1:4 bonus issue, Asset book of Rs 8,86,723 crore
-
Rs 325,00,00,000 Buy back announced by the company, Record date August 25, Stock surged by 5 per cent today
-
1000 per cent returns in 3 years: Keep a close eye on this smallcap stock which bagged a huge international client!
-
Low PE High ROE stock: This small-cap company receives multiple projects worth Rs 123.38 crore!
-
Stock below Rs 50: This small-cap company received a work order worth Rs 29,85,000!
-
This mid-cap company wins new orders worth Rs 3,023 crore!
-
Stock below Rs 15: This small-cap company emerges as the Lowest Bidder (L1) for new orders worth Rs 15,676.24 million!
-
Keep an eye on this stock, which was locked in the upper circuit on February 13
-
Watch out for these penny stocks locked in the upper circuit on February 08
-
Keep an eye on this stock, which was locked in the upper circuit on February 06
-
Multibagger stock below Rs 20: Investors should keep an eye on this small-cap stock!